Statistical Issues in Toxicokinetic Modeling: A Bayesian Perspective, Environmental Health Perspectives, vol.108, issue.s5, pp.883-93, 2000. ,
DOI : 10.1289/ehp.00108s5883
URL : https://hal.archives-ouvertes.fr/ineris-00961852
Physiological parameter values for physiologically based pharmacokinetic models Basic Anatomical and Physiological data for Use in Radiological Protection: Reference Values, Toxicol Ind Health International Commission on Radiological Protection (ICRP), vol.13, issue.526, pp.407-84, 1995. ,
Bayesian Theory, 1994. ,
DOI : 10.1002/9780470316870
The Bayesian Modeling of Covariates for Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.43, issue.435, pp.917-944, 1996. ,
DOI : 10.2307/2986121
Modélisation toxicocinétique de la concentration sanguine de 2,3,7,8- tetrachloro-p-dioxine après ingestion chez la femme, Environnement, Risques et Santé, vol.2, 2003. ,
Clearance concepts in pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.58, issue.2, pp.123-159, 1973. ,
DOI : 10.1007/BF01059626
Concepts basic to pharmacokinetics, Pharmacology & Therapeutics, vol.12, issue.1, pp.109-140, 1981. ,
DOI : 10.1016/0163-7258(81)90077-2
Occupational Exposures to Mists and Vapours from Strong Inorganic Acids and Other Industrial Chemicals International Agency for Research on Cancer Optimal design for a study of butadiene toxicokinetics in humans Evaluation of methods for estimating population pharmacokinetic parameters -I. Michaelis-Menten model: routine clinical pharmacokinetic data, International Agency for Research on Cancer (IARC) Toxicological Sciences: an Official Journal of the Society of Toxicology Journal of Pharmacokinetics and Biopharmaceutics, vol.440, issue.8, pp.11-12, 1980. ,
Estimating population kinetics, CRC Critical Reviews in Biomedical Engineering, vol.8, pp.195-222, 1982. ,
Population pharmacokinetics Population toxicokinetics of tetrachloroethylene Physiological pharmacokinetic analysis using population modeling and informative prior distributions Markov chain Monte Carlo convergence diagnostics: a comparative review, International Journal of Clinical Pharmacology, Therapy, and Toxicology Archives of Toxicology Journal of the American Statistical Association Journal of the American Statistical Association, vol.30, issue.91, pp.520-522, 1992. ,
A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human, British Journal of Clinical Pharmacology Toxicol Appl Pharmacol Toxicol Appl Pharmacol, vol.50, issue.22, pp.135-180, 2000. ,
The Importance of Anatomical Realism for Validation of Physiological Models of Disposition of Inhaled Toxicants, Toxicology and Applied Pharmacology, vol.147, issue.2, pp.448-58, 1997. ,
DOI : 10.1006/taap.1997.8289
Bayesian Optimal Design via Interacting MCMC, Cahiers du Ceremade, pp.34-58, 2004. ,
Simulation Based Optimal Design BUGS: a program to perform Bayesian inference using Gibbs sampling MCSim: a simulation program Chang I. Application of NONMEM to routine bioavailability data, M. Application of the NONMEM method to evaluation of the bioavailability of drug products, pp.459-74, 1988. ,
UCSF NONMEM software. licensed and distributed by GloboMax LLC: http://c255.ucsf.edu/nonmem0.html. 30. Claret L, Iliadis A. Nonparametric density estimation applied to population pharmacokinetics, Math Biosci, vol.133, pp.51-68, 1996. ,
Some adaptive Monte Carlo methods for Bayesian inference, Statistics in Medicine, vol.43, issue.17-18, pp.2507-2522, 1999. ,
DOI : 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2507::AID-SIM272>3.0.CO;2-J